A South Korean life sciences company plans to open a genetic testing lab in North Austin, a move that could create up to 200 ...

New peptide research blend shows promise as a game-changer in the fitness space BURTON, MI, UNITED STATES, January 19, ...

The biopharmaceutical company may start to offer two cancer therapies and an additional HIV treatment option this year.

They work inside integrated development environments (IDEs), where code, documentation, testing, version history and ...

Anavex Life Sciences (AVXL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is one ...

Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the fourth quarter and full year 2025.

Dr. Cindi Love, Executive Director of Out for Undergrad, emphasized the significance of Valladares’ appointment: ...

Roivant saw its share prices jump by 19.4 percent week-on-week, hitting a new all-time high, as investors snapped up shares ...

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people.

Gilead's revenue is anchored by Biktarvy, protected by exclusivity through 2036, reducing near-term patent cliff risk vs. peers. Learn more about GILD stock here.

A professor and chair of UAMS’ Department of Orthopaedic Surgery, C. Lowry Barnes was selected as one of four finalists in a ...